US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 26.290
  • -0.180-0.68%
Close Nov 26 16:00 ET
  • 26.290
  • 0.0000.00%
Post 20:01 ET
11.68BMarket Cap10.35P/E (TTM)

Royalty Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
5.29%564.69M
-0.17%537.27M
-16.96%567.98M
5.24%2.35B
5.36%596.07M
-6.48%536.31M
0.42%538.2M
21.69%683.97M
-2.28%2.24B
-1.73%565.75M
Operating revenue
5.29%564.69M
-0.17%537.27M
-16.96%567.98M
5.24%2.35B
5.36%596.07M
-6.48%536.31M
0.42%538.2M
21.69%683.97M
-2.28%2.24B
-1.73%565.75M
Cost of revenue
Gross profit
Operating expense
-144.27%-170.38M
-7.51%267.64M
213.05%641.75M
-34.38%862.4M
-103.89%-16.83M
0.95%384.87M
82.95%289.36M
-40.12%205M
53.05%1.31B
2.44%432.58M
Selling and administrative expenses
-0.90%56.72M
14.85%54.71M
-32.72%57.65M
9.87%249.75M
-19.18%59.19M
12.91%57.23M
-8.12%47.63M
66.27%85.7M
24.33%227.3M
58.64%73.23M
-General and administrative expense
-0.90%56.72M
14.85%54.71M
-32.72%57.65M
9.87%249.75M
-19.18%59.19M
12.91%57.23M
-8.12%47.63M
66.27%85.7M
24.33%227.3M
58.64%73.23M
Research and development costs
-99.01%500K
0.00%500K
0.00%500K
-70.64%52M
-99.01%500K
98.04%50.5M
-17.49%500K
-99.50%500K
-11.48%177.11M
-51.36%50.5M
Depreciation amortization depletion
----
----
----
--0
----
----
----
----
-75.34%5.67M
--0
-Depreciation and amortization
----
----
----
--0
----
----
----
----
-75.34%5.67M
--0
Other operating expenses
-182.13%-227.6M
-11.94%212.43M
391.23%583.6M
-38.00%560.66M
-124.77%-76.51M
-9.15%277.14M
128.19%241.23M
-35.65%118.8M
99.68%904.24M
15.89%308.85M
Operating profit
385.38%735.07M
8.35%269.63M
-115.40%-73.77M
61.68%1.49B
360.23%612.9M
-21.21%151.44M
-34.13%248.84M
117.99%478.97M
-35.49%922.89M
-13.20%133.17M
Net non-operating interest income expense
-116.83%-49M
-67.32%-35.63M
-21.71%-36.82M
-4.81%-114.9M
-1,213.83%-40.76M
31.41%-22.6M
40.92%-21.3M
19.41%-30.25M
2.65%-109.63M
91.46%-3.1M
Non-operating interest income
-25.29%17.51M
-47.84%13.38M
-55.59%7.42M
-7.72%72.29M
-85.18%6.5M
66.99%23.44M
134.94%25.65M
75.28%16.7M
46.32%78.34M
312.19%43.85M
Non-operating interest expense
44.47%66.51M
4.40%49.01M
-5.79%44.23M
-0.41%187.19M
0.64%47.26M
-2.01%46.03M
-0.04%46.95M
-0.24%46.95M
13.13%187.96M
-0.04%46.96M
Other net income (expense)
1,877.22%120.28M
-132.01%-39.62M
76.12%106.32M
155.36%322.83M
119.65%145.45M
-111.07%-6.77M
-17.39%123.79M
211.58%60.37M
-658.32%-583.2M
-1,067.15%-740.1M
Gain on sale of security
69,172.67%111.53M
-138.33%-47.32M
334.52%124.15M
460.20%315.69M
240.63%163.49M
-99.79%161K
-17.77%123.47M
154.17%28.57M
208.92%56.35M
-465.18%-116.25M
Earnings from equity interest
299.29%10.41M
321.17%1.7M
-140.89%-14.15M
421.88%28.88M
103.91%268K
-60.63%-5.22M
-204.48%-770K
8,616.88%34.61M
53.96%-8.97M
81.97%-6.86M
Special income (charges)
----
----
----
--0
----
----
----
----
---615.83M
----
-Write off
----
----
----
--0
----
----
----
----
--615.83M
----
Other non- operating income (expenses)
3.10%-1.65M
449.95%6M
-31.00%-3.69M
-47.32%-21.74M
-1,471.50%-18.31M
84.19%-1.71M
205.41%1.09M
-60.10%-2.81M
-159.86%-14.76M
75.83%-1.17M
Income before tax
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
638.96%1.7B
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-81.46%230.06M
-1,236.61%-610.03M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
638.96%1.7B
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-81.46%230.06M
-1,236.61%-610.03M
Net income continuous Operations
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
638.96%1.7B
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-81.46%230.06M
-1,236.61%-610.03M
Minority interest income
425.13%262.37M
-25.33%92.37M
-105.38%-9.05M
201.90%565.25M
245.02%223.25M
-35.75%49.96M
-33.88%123.71M
120.56%168.33M
-69.87%187.23M
-436.37%-153.95M
Net income attributable to the parent company
654.34%543.99M
-55.19%102M
-98.60%4.78M
2,549.50%1.13B
208.39%494.34M
-49.45%72.11M
-25.25%227.63M
558.32%340.76M
-93.09%42.83M
-5,870.29%-456.08M
Preferred stock dividends
Other preferred stock dividends
-392.73M
Net income attributable to common stockholders
654.34%543.99M
-55.19%102M
-98.60%4.78M
3,466.40%1.53B
294.50%887.07M
-49.45%72.11M
-25.25%227.63M
558.32%340.76M
-93.09%42.83M
-5,870.29%-456.08M
Basic earnings per share
662.50%1.22
-54.90%0.23
-98.68%0.01
2,440.00%2.54
206.73%1.11
-50.00%0.16
-27.14%0.51
533.33%0.76
-93.29%0.1
-1.04
Diluted earnings per share
656.25%1.21
-54.00%0.23
-98.68%0.01
2,430.00%2.53
174.96%1.1
-50.00%0.16
-28.57%0.5
533.33%0.76
-93.29%0.1
-122.01%-1.4675
Dividend per share
5.00%0.21
5.00%0.21
5.00%0.21
5.26%0.8
5.26%0.2
5.26%0.2
5.26%0.2
5.26%0.2
11.76%0.76
11.76%0.19
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 5.29%564.69M-0.17%537.27M-16.96%567.98M5.24%2.35B5.36%596.07M-6.48%536.31M0.42%538.2M21.69%683.97M-2.28%2.24B-1.73%565.75M
Operating revenue 5.29%564.69M-0.17%537.27M-16.96%567.98M5.24%2.35B5.36%596.07M-6.48%536.31M0.42%538.2M21.69%683.97M-2.28%2.24B-1.73%565.75M
Cost of revenue
Gross profit
Operating expense -144.27%-170.38M-7.51%267.64M213.05%641.75M-34.38%862.4M-103.89%-16.83M0.95%384.87M82.95%289.36M-40.12%205M53.05%1.31B2.44%432.58M
Selling and administrative expenses -0.90%56.72M14.85%54.71M-32.72%57.65M9.87%249.75M-19.18%59.19M12.91%57.23M-8.12%47.63M66.27%85.7M24.33%227.3M58.64%73.23M
-General and administrative expense -0.90%56.72M14.85%54.71M-32.72%57.65M9.87%249.75M-19.18%59.19M12.91%57.23M-8.12%47.63M66.27%85.7M24.33%227.3M58.64%73.23M
Research and development costs -99.01%500K0.00%500K0.00%500K-70.64%52M-99.01%500K98.04%50.5M-17.49%500K-99.50%500K-11.48%177.11M-51.36%50.5M
Depreciation amortization depletion --------------0-----------------75.34%5.67M--0
-Depreciation and amortization --------------0-----------------75.34%5.67M--0
Other operating expenses -182.13%-227.6M-11.94%212.43M391.23%583.6M-38.00%560.66M-124.77%-76.51M-9.15%277.14M128.19%241.23M-35.65%118.8M99.68%904.24M15.89%308.85M
Operating profit 385.38%735.07M8.35%269.63M-115.40%-73.77M61.68%1.49B360.23%612.9M-21.21%151.44M-34.13%248.84M117.99%478.97M-35.49%922.89M-13.20%133.17M
Net non-operating interest income expense -116.83%-49M-67.32%-35.63M-21.71%-36.82M-4.81%-114.9M-1,213.83%-40.76M31.41%-22.6M40.92%-21.3M19.41%-30.25M2.65%-109.63M91.46%-3.1M
Non-operating interest income -25.29%17.51M-47.84%13.38M-55.59%7.42M-7.72%72.29M-85.18%6.5M66.99%23.44M134.94%25.65M75.28%16.7M46.32%78.34M312.19%43.85M
Non-operating interest expense 44.47%66.51M4.40%49.01M-5.79%44.23M-0.41%187.19M0.64%47.26M-2.01%46.03M-0.04%46.95M-0.24%46.95M13.13%187.96M-0.04%46.96M
Other net income (expense) 1,877.22%120.28M-132.01%-39.62M76.12%106.32M155.36%322.83M119.65%145.45M-111.07%-6.77M-17.39%123.79M211.58%60.37M-658.32%-583.2M-1,067.15%-740.1M
Gain on sale of security 69,172.67%111.53M-138.33%-47.32M334.52%124.15M460.20%315.69M240.63%163.49M-99.79%161K-17.77%123.47M154.17%28.57M208.92%56.35M-465.18%-116.25M
Earnings from equity interest 299.29%10.41M321.17%1.7M-140.89%-14.15M421.88%28.88M103.91%268K-60.63%-5.22M-204.48%-770K8,616.88%34.61M53.96%-8.97M81.97%-6.86M
Special income (charges) --------------0-------------------615.83M----
-Write off --------------0------------------615.83M----
Other non- operating income (expenses) 3.10%-1.65M449.95%6M-31.00%-3.69M-47.32%-21.74M-1,471.50%-18.31M84.19%-1.71M205.41%1.09M-60.10%-2.81M-159.86%-14.76M75.83%-1.17M
Income before tax 560.53%806.36M-44.67%194.38M-100.84%-4.27M638.96%1.7B217.63%717.59M-44.61%122.08M-28.53%351.34M297.47%509.09M-81.46%230.06M-1,236.61%-610.03M
Income tax 0000000000
Net income 560.53%806.36M-44.67%194.38M-100.84%-4.27M638.96%1.7B217.63%717.59M-44.61%122.08M-28.53%351.34M297.47%509.09M-81.46%230.06M-1,236.61%-610.03M
Net income continuous Operations 560.53%806.36M-44.67%194.38M-100.84%-4.27M638.96%1.7B217.63%717.59M-44.61%122.08M-28.53%351.34M297.47%509.09M-81.46%230.06M-1,236.61%-610.03M
Minority interest income 425.13%262.37M-25.33%92.37M-105.38%-9.05M201.90%565.25M245.02%223.25M-35.75%49.96M-33.88%123.71M120.56%168.33M-69.87%187.23M-436.37%-153.95M
Net income attributable to the parent company 654.34%543.99M-55.19%102M-98.60%4.78M2,549.50%1.13B208.39%494.34M-49.45%72.11M-25.25%227.63M558.32%340.76M-93.09%42.83M-5,870.29%-456.08M
Preferred stock dividends
Other preferred stock dividends -392.73M
Net income attributable to common stockholders 654.34%543.99M-55.19%102M-98.60%4.78M3,466.40%1.53B294.50%887.07M-49.45%72.11M-25.25%227.63M558.32%340.76M-93.09%42.83M-5,870.29%-456.08M
Basic earnings per share 662.50%1.22-54.90%0.23-98.68%0.012,440.00%2.54206.73%1.11-50.00%0.16-27.14%0.51533.33%0.76-93.29%0.1-1.04
Diluted earnings per share 656.25%1.21-54.00%0.23-98.68%0.012,430.00%2.53174.96%1.1-50.00%0.16-28.57%0.5533.33%0.76-93.29%0.1-122.01%-1.4675
Dividend per share 5.00%0.215.00%0.215.00%0.215.26%0.85.26%0.25.26%0.25.26%0.25.26%0.211.76%0.7611.76%0.19
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data